Curdione at low, medium, and high doses obviously increased METTL14 expression (P < 0.01), as displayed by the bar graph, with CRC mice administered a high dose of 50 mg/kg intervention having nearly five times more METTL14 expression compared to the control group. The gene discussed is METTL14; the disease is colorectal carcinoma.